Clinical Trials Logo

Personal Satisfaction clinical trials

View clinical trials related to Personal Satisfaction.

Filter by:

NCT ID: NCT06416943 Not yet recruiting - Cancer Clinical Trials

3D Port-A Catheter Model for New Staff

Start date: June 1, 2024
Phase: N/A
Study type: Interventional

The aim of this study is to develop a highly realistic 3D-printed Port-A catheter upper body model to enhance the effectiveness of training new nursing staff in Port-A catheter placement and care skills.

NCT ID: NCT05953870 Completed - Stress Clinical Trials

This is a Study to Evaluate if Music Therapy Can Reduce Stress and Increase Satisfaction of Patients Undergoing Ambulatory Surgery

Start date: July 20, 2023
Phase: N/A
Study type: Interventional

Patients who undergo outpatient surgery according to normal practice will be divided into two groups. The first group (17 patients), before and after their surgery, will listen to relaxing music, namely a slower tempo music that can quiet mind and make patients feel soothed. The second group (17 patients) will follow the standard surgical pathways according to normal clinical practice, in particular they will not listen to relaxing music. A questionnaire to evaluate stress and satisfaction will be administered to all the patients before their discharge

NCT ID: NCT05372978 Recruiting - Clinical trials for Personal Satisfaction

Cash Transfers for People Experiencing Homelessness

Start date: May 2, 2022
Phase: N/A
Study type: Interventional

The primary goal of the study is to determine the impacts of a one-time unconditional cash transfer on the well-being of people experiencing homelessness.

NCT ID: NCT05284591 Active, not recruiting - Multiple Myeloma Clinical Trials

Non-interventional Study to Evaluate Patient and Healthcare Provider Satisfaction of Daratumumab Use in the Treatment of First-line Daratumumab, Lenalidomide, Dexamethasone (DRd) Multiple Myeloma Patients in Germany Depending on Application Route (sc or iv)

MYLENE
Start date: July 6, 2022
Phase:
Study type: Observational

MYLENE is a prospective, multicenter, NIS to evaluate the patient and HCP satisfaction of sc and iv application of daratumumab in routine clinical practice in Germany. Patients observed in this study will be transplant ineligible NDMM patients for which the physician foresees an anti-myeloma therapy using DRd regimen as per local label. 250 NDMM patients treated with DRd will be enrolled (excluding screening failures, i.e., enrolled patients not fulfilling selection criteria identified before treatment start will be replaced) within 12 months in a proportion of approximately 1/3 patients receiving daratumumab sc and 2/3 patients receiving daratumumab iv as per physician's decision.

NCT ID: NCT05264844 Completed - Pain Clinical Trials

Peripheral Venous Catheter and Masking Tape

Start date: May 1, 2022
Phase: N/A
Study type: Interventional

urpose: This study will be carried out to determine the effect of two different catheter covers on the comfort, satisfaction, pain level of the patient and the satisfaction of the nurse. Materials and Methods: This study, which is planned as an open-label randomized controlled post-test study, will be carried out between December 2021 and February 2022. Data; Descriptive Properties will be collected with the Information Form and Visual Analog Scale (Visual Analog Scale-VAS). Data will be collected face to face by researchers.

NCT ID: NCT04935541 Completed - Geriatrics Clinical Trials

Dexmedetomidine vs. Remifentanil Undergoing Cataract Surgery in Geriatrics

Start date: March 2009
Phase: N/A
Study type: Interventional

Dexmedetomidine is an α2-adrenergic receptor agonist used for its sympatholytic effect, providing sedation, analgesia, and cardiovascular stabilization in the perioperative period. Remifentanil is a µ opioid agonist with a rapid onset and short duration of action, which is degraded by plasma esterase in tissues. Investigators aimed to compare the effects of dexmedetomidine and remifentanil infusions on sedation quality, side effects, and surgeon's satisfaction in geriatric outpatients who underwent cataract surgery.

NCT ID: NCT04757428 Completed - Clinical trials for Personal Satisfaction

Clinical Evaluation of Lithium Disilicate (e.Max) and Hybrid Nano-ceramic (Grandio) CAD/CAM Endocrowns

Start date: January 11, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to compare marginal adaptation, fracture, retention, shade matching and patient satisfaction between lithium disilicate (e.max) and hybrid nano-ceramic (Grandio) CAD/CAM endocrowns.

NCT ID: NCT04446143 Completed - Clinical trials for Personal Satisfaction

Effects on Mindfulness Meditation on Patient's Satisfaction During Urodynamic Study

Start date: December 1, 2020
Phase: N/A
Study type: Interventional

The purpose of this investigator-initiated study is to evaluate if mindfulness-based stress reduction (MBSR) will improve satisfaction and reduce anxiety during a urodynamic study (UDS).

NCT ID: NCT03360773 Completed - Depression Clinical Trials

Emotional Fluctuations in the Flow of Daily Life. Ecological Analysis of Depressive Symptoms in the General Population.

FEDD
Start date: March 10, 2018
Phase:
Study type: Observational

The aim of this study is to analyze both depressive symptomatology and psychological well-being fluctuation in a day-to-day basis in the general population, in order to identify contextual determinants of the mood and well-being changes

NCT ID: NCT03116607 Completed - Clinical trials for Personal Satisfaction

Pharmaceutical Intervention Program at Readmission and User Satisfaction in a Emergency Department

Start date: March 2015
Phase: N/A
Study type: Interventional

A randomized clinical trial with two parallel groups (control and intervened) in the Emergency Department (ED) at the Clinical Hospital of the University of Chile will take place. The sample will be of 996 patients (498 per group). The control group will receive hospital care and discharge plan usual, while the intervention group also receive a Program of Pharmaceutical Interventions while in the service and at discharge, which includes an analysis of the therapy recommended by the physician, assessing the safer alternatives for the patient population and the special conditions of their pathology, emphasizing evaluations of effectiveness, safety and tolerability of medication, drug interactions, potential adverse events, dose adjustments as needed according to the patient's condition ; verification that the administration is optimal, including choosing the best route to this and the time when the drugs are infused into the patient.Interventions aimed at patient occur during the stay and at discharge, focusing on clarifying administration regimens, reasons for using drugs, prevent drug-related problems, clarify doubts and educate about pharmacotherapy and make a reinforcement of adherence. The selection and patient recruitment will take place during the first hour of admission to care box, where they were invited to participate and signed informed consent. In both groups, a doctor and a pharmacist, blind to treatment assignment, will gather information during the stay, discharge and post-discharge, the latter by telephone 30 days after discharge from the ED, in this second interview also verify the existence of a readmission and / or unscheduled medical consultation. In addition, discharge of each patient satisfaction was measured with respect to the service received by a user satisfaction survey applied by external and impartial staff. In addition, two independent trained evaluators (Emergency Medical and Pharmaceutical Chemistry), blinded to treatment assignment, evaluate the background of each case and by consensus allocated the presence of problems related to drugs, and classified as preventable or not preventable, according severity. X2 test or Fisher exact test was used to test the hypothesis that the Programme of Pharmaceutical Interventions decreases at least 30% the user dissatisfaction compared with usual care in the ED.